Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa.

Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia.
BMC Microbiology (Impact Factor: 3.1). 11/2008; 8:198. DOI: 10.1186/1471-2180-8-198
Source: PubMed

ABSTRACT Streptococcus pneumoniae serotype 1 causes > 20% of invasive disease, among all age groups combined, in The Gambia. In contrast, it is rarely detected in carriage studies. This study compares the molecular epidemiology of S. pneumoniae serotype 1 causing invasive disease in The Gambia between 1996 and 2005 to those carried in the nasopharynx between 2004 and 2006.
A total of 127 invasive and 36 nasopharyngeal carriage serotype 1 isolates were recovered from individuals of all age groups and were analyzed by serotyping, antibiotic susceptibility testing and MLST. MLST analysis revealed 23 different sequence types (STs), 18 of which were novel. The most prevalent clone among the 163 isolates was ST618 (70.5%), followed by ST3575 (7.4%), ST2084 (2.5%) and ST612 (2.5%). A single ST (ST618), previously shown to belong to the ST217 hypervirulent clonal complex, was frequent among carriage (61.1%) and invasive (72.7%) serotype 1 isolates. ST618 causing both paediatric and adult disease peaked annually in the hot dry season and caused outbreak in 1997 and 2002.
For over a decade, isolates of ST618 have been the dominant lineage among serotype 1 carriage and disease isolates circulating in the Gambia. This lineage shows similar epidemiological features to those of the meningococcus in the African meningitis belt being able to cause outbreaks of disease.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Streptococcus pneumoniae infection is a serious problem worldwide and the case fatality rate remains high. The aim of this study was to analyze the distribution of pneumococcal serotypes causing invasive pneumococcal disease (IPD), to survey the potential coverage of present and future vaccines, and to investigate differences between serotypes and groups of serotypes with regard to manifestation, case fatality rate, age, and other risk factors. Isolates from 244 consecutive patients with IPD were collected at the Christian Medical College, Vellore, India between January 2007 and June 2011, and clinical data were obtained retrospectively. Clinical characteristics were analyzed both for individual serotypes and for those grouped as "invasive", "pediatric", or "vaccine" serotypes. The serotype coverage for the pneumococcal conjugated vaccines (PCV) PCV7, PCV10, PCV13, PCV15, and pneumococcal polysaccharide vaccine (PPV) PPV23 was 29%, 53%, 64%, 66%, and 73%, respectively. The proportion of IPD caused by vaccine types was lower than pre-vaccination studies from other parts of the world. In adults, serotype 1 was mainly isolated from previously healthy patients without risk factors for IPD. This serotype caused more pneumonia and less meningitis than other serotypes, as was also noted for the "invasive" serotypes (1, 5, and 7 F). The most common pneumococcal serotypes in this study behaved in similar ways to those in countries where the PCV has been introduced. Also, the most common serotypes in this study are included in the new PCVs. Therefore, a national program of childhood immunization with PCV10/13 in India is likely to be successful.
    BMC Infectious Diseases 11/2013; 13(1):532. · 3.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV) era. A search for pneumococcal carriage studies published before 2012 was conducted to describe carriage in sSA. The review also describes pneumococcal serotypes and assesses the impact of vaccination on carriage in this region. Fifty-seven studies were included in this review with the majority (40.3%) from South Africa. There was considerable variability in the prevalence of carriage between studies (I-squared statistic = 99%). Carriage was higher in children and decreased with increasing age, 63.2% (95% CI: 55.6-70.8) in children less than 5 years, 42.6% (95% CI: 29.9-55.4) in children 5-15 years and 28.0% (95% CI: 19.0-37.0) in adults older than 15 years. There was no difference in the prevalence of carriage between males and females in 9/11 studies. Serotypes 19F, 6B, 6A, 14 and 23F were the five most common isolates. A meta-analysis of four randomized trials of PCV vaccination in children aged 9-24 months showed that carriage of vaccine type (VT) serotypes decreased with PCV vaccination; however, overall carriage remained the same because of a concomitant increase in non-vaccine type (NVT) serotypes. Pneumococcal carriage is generally high in the African continent, particularly in young children. The five most common serotypes in sSA are among the top seven serotypes that cause invasive pneumococcal disease in children globally. These serotypes are covered by the two PCVs recommended for routine childhood immunization by the WHO. The distribution of serotypes found in the nasopharynx is altered by PCV vaccination.
    PLoS ONE 01/2014; 9(1):e85001. · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectif Le but de ce travail était de déterminer les caractéristiques épidémiologiques des infections invasives méningées et pulmonaires dues à Streptococcus pneumoniae au Burkina Faso. Matériel et méthodes S. pneumoniae a été recherché par des techniques de bactériologie classique et par PCR en temps réel (rt-PCR) dans 7917 échantillons de liquides céphalorachidiens (LCR) et de liquides pleuraux (LP) collectés au CHU Yalgado de Ouagadougou de 2007 à 2011. Résultats S. pneumoniae a été identifié dans 476 (6 %) des échantillons analysés dont 455 (5,7 %) dans les LCR et 21 (0,3 %) dans les LP. Soixante-sept pour cent des infections invasives confirmées sont survenus chez les patients de 15 ans et moins. Aucune différence significative n’était associée au sexe des patients. Les cas surviennent entre janvier et août principalement, avec un premier pic entre janvier et mai (saison sèche) plus important que le second observé entre juin et août (début d’hivernage). L’introduction de la rt-PCR a montré une sous-notification des cas confirmés d’infections invasives pneumococciques par les techniques bactériologiques classiques (détection de l’antigène capsulaire soluble par des particules de latex sensibilisées et culture). Conclusion Les infections invasives pneumococciques surviennent dans toutes les tranches d’âge, avec une fréquence plus élevée chez les 15 ans et moins, sans distinction de sexe et avec des pics en saison sèche. Les perspectives vaccinales devraient prendre en compte toutes les tranches d’âges des populations du pays.
    Médecine et Maladies Infectieuses 01/2014; · 0.75 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014